Watchlist for February 27, 2008

See one of the recent 'Chart Reading' posts for some potential swing candidates. Also be sure to check my typical swing trade entry & exit rules.

Potential day trades:

(From Briefing.com)

Gapping Down

In reaction to weak earnings/guidance: ADSK -13.0% (also downgraded to Hold at Needham and downgraded to Accumulate at ThinkEquity), DY -8.8%, LAMR -8.7%, NT -8.3%, URS -7.1%, CRI -6.5%, ESST -5.9%, DRC -5.3%, BTUI -5.1%, APSG -4.8%, FNM -4.5%, DYN -4.4%, OSG -4.3%, CVTX -3.6%, IHP -3.1%, BMRN -2.9%, BID -2.8%, RRC -2.7%, TX -2.6%, SQM -2.1%, SCRX -1.7%, MGA -1.4%, ORA -1.4%... Select solar stocks showing weakness following multiple downgrades: JASO -8.1% (downgraded to Neutral at BofA), SOLF -6.6% (downgraded to Sell at BofA), TSL -5.0% (downgraded to Sell at BofA), YGE -4.7% (downgraded to Neutral at BofA), LDK -1.5%, ESLR -1.4%, FSLR -1.2%... Select agriculture names showing weakness: CF -2.6%, TRA -2.5%, MOS -2.3%, AGU -2.2%, POT -2.2%, MON -1.8%... Other news: RJA -4.7% (still checking), EEP -3.8% (announces an offering of ~4 mln of its Class A common units), FRE -2.9% (down in sympathy with FNM), CF -2.9% (reports outage at its Medicine Hat, Alberta Nitrogen complex), ENS -2.7% (registers to sell 5 mln shares of common stock for holders), DAL -2.6% (CEO Anderson says no merger agreement yet with Northwest Air), AZN -2.2% (stopping study on the experimental cancer drug Recentin - DJ), KMP -1.9% (files for a 4.3 mln common unit secondary offering), JPM -1.4% (estimates cut at Citigroup), AMGN -1.6% and JNJ -1.1% (anemia drugs have blood clot, death risk, according to study - DJ)... Analyst downgrades: COST -2.2% (hearing downgraded to Neutral at tier 1 firm), EOG -1.6% (downgraded to Hold at Citigroup), CHK -1.5% (downgraded to Hold at Citigroup), GLNG -1.4% (downgraded to Hold at Jefferies), KWK -1.0% (downgraded to Hold at Citigroup).

Gapping Up

In reaction to strong earnings/guidance: ACY +32.2% (restates 2006 and 2007 quarterly results), HCKT +16.9%, EDAC +13.1%, LKQX +11.5%, ERES +10.3%, DWA +7.6%, SGY +7.6%, WRNC +6.4%, AXTI +5.7% (also upgraded to Buy at Roth Capital), HLF +5.6%, PCR +5.2%, VPHM +5.1%, MXWL +5.0%, SBLK +4.8%, ENOC +4.7%, SONE +4.0%, ARUN +3.9%, NFLX +3.8%, IRIS +3.3% (also announces successful completion of retrospective study of 85 post-prostatectomy patients), VSNT +3.2%, PZZA +3.1%, STO +2.9%, MEDX +2.7% (also upgraded to Mkt Perform at BMO), TVL +1.5%, BARE +1.4%, COGT +1.4%, CVA +1.1%, TRCA +1.0%... Select gold stocks showing strength with higher spot prices: DROOY +4.2%, GFI +2.7%, GLD +1.2%, HMY +1.0%, NEM +1.0%... Other news: ANO +6.3% (still checking), TTEK +3.1% (awarded $3 bln program ceiling contract to support Air Force Center for Engineering and the Environment), STM +2.9% (still checking), FRO +2.2% (still checking), WST +1.7% (will replace SIE in S&P SmallCap 600 after the close of trading on 2/28), CRXX +1.0% (granted broad patent covering TCA-Glucocorticoid Combinations)... Analyst upgrades: THC +8.2% (upgraded to Hold at Jefferies), PRXI +7.8% (initiated with Buy at Merriman), XLNX +1.5% (upgraded to Buy at UBS).

Disclaimer & How I use this list